We are live on ! Find out more
EA

Emerald Acquisition Portfolio holdings

AUM $51.8B
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$57.7B
AUM Growth
Cap. Flow
+$57.1B
Cap. Flow %
98.97%
Top 10 Hldgs %
10.09%
Holding
2,993
New
2,993
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$755M
2
MSFT icon
Microsoft
MSFT
+$711M
3
WFC icon
Wells Fargo
WFC
+$630M
4
TSM icon
TSMC
TSM
+$575M
5
JPM icon
JPMorgan Chase
JPM
+$549M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 17.76%
2 Healthcare 12.74%
3 Technology 11.3%
4 Industrials 10.13%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFL icon
276
Aflac
AFL
$62.9B
$48.6M 0.08%
+1,346,650
New +$46M
ED icon
277
Consolidated Edison
ED
$40.9B
$48.5M 0.08%
+603,632
New +$45.4M
BWXT icon
278
BWX Technologies
BWXT
$15.9B
$48.4M 0.08%
+1,353,338
New +$46.3M
EA icon
279
Electronic Arts
EA
$52.4B
$47.7M 0.08%
+629,731
New +$44.3M
CSC
280
DELISTED
Computer Sciences
CSC
$47.6M 0.08%
+959,143
New +$38.8M
MS icon
281
Morgan Stanley
MS
$340B
$47.5M 0.08%
+1,830,173
New +$47.9M
F icon
282
Ford
F
$56.9B
$47.5M 0.08%
+3,781,138
New +$49.8M
APD icon
283
Air Products & Chemicals
APD
$66.1B
$47.5M 0.08%
+361,555
New +$48.1M
UN
284
DELISTED
Unilever NV New York Registry Shares
UN
$47.4M 0.08%
+1,010,546
New +$45.3M
UTHR icon
285
United Therapeutics
UTHR
$26.4B
$47.4M 0.08%
+447,202
New +$49.9M
DXCM icon
286
DexCom
DXCM
$29.2B
$47.3M 0.08%
+2,388,972
New +$40.7M
PYPL icon
287
PayPal
PYPL
$49.3B
$47.2M 0.08%
+1,292,165
New +$49.4M
YPF icon
288
YPF
YPF
$20.1B
$47.1M 0.08%
+2,454,868
New +$48.8M
AMP icon
289
Ameriprise Financial
AMP
$47.3B
$46.9M 0.08%
+522,387
New +$50.5M
GGG icon
290
Graco
GGG
$12.2B
$46.7M 0.08%
+1,774,935
New +$47.7M
COP icon
291
ConocoPhillips
COP
$143B
$46.7M 0.08%
+1,070,087
New +$47.2M
EXR icon
292
Extra Space Storage
EXR
$31.1B
$46.5M 0.08%
+503,654
New +$45.5M
CEO
293
DELISTED
CNOOC Limited
CEO
$46.1M 0.08%
+369,576
New +$44.5M
ABBV icon
294
AbbVie
ABBV
$452B
$46M 0.08%
+743,087
New +$45.3M
PGR icon
295
Progressive
PGR
$123B
$46M 0.08%
+1,373,513
New +$45.4M
CLX icon
296
Clorox
CLX
$11.6B
$45.9M 0.08%
+331,938
New +$43M
HAL icon
297
Halliburton
HAL
$27.7B
$45.8M 0.08%
+1,011,333
New +$41.6M
RYAAY icon
298
Ryanair
RYAAY
$30.5B
$45.6M 0.08%
+1,638,118
New +$53.1M
GIS icon
299
General Mills
GIS
$19.8B
$45.2M 0.08%
+633,785
New +$40.3M
BAX icon
300
Baxter International
BAX
$11.4B
$45M 0.08%
+995,501
New +$43.7M

Similar funds

Emerald Acquisition's Q2 2016 Portfolio in Review

Q2 2016 is the first quarter with a 13F filing on record for Emerald Acquisition, which disclosed 2,993 positions worth $57.7B. Its ten largest holdings account for 10% of the portfolio.

Its largest position is Johnson & Johnson: 6,642,592 shares worth $805M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, followed by Healthcare and Technology.

  • Emerald Acquisition's largest Q2 2016 buy was Johnson & Johnson: 6,642,592 shares worth $805M.
  • Emerald Acquisition's ten largest holdings make up 10% of its $57.7B portfolio in Q2 2016.
  • Emerald Acquisition disclosed 2,993 positions in Q2 2016, its first 13F filing on record.

Based on Emerald Acquisition's 13F filing for Q2 2016, filed 3 Aug 2016.